Robert L. Rosiello's most recent trade in Sana Biotechnology Inc was a trade of 115,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sana Biotechnology Inc | Robert L. Rosiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Omega Therapeutics Inc | Robert L. Rosiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | Robert L. Rosiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | Robert L. Rosiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |